Koers Lonza Group AG Swiss Exchange
Aandelen
CH0013841017
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- CHF | - |
14/05 | Zwitserse beursindex loopt op in aanloop naar inflatierapport | MT |
14/05 | Transcript : Lonza Group AG, Q1 2024 Earnings Call, May 14, 2024 |
Omzet 2024 * | 6,66 mld. 7,39 mld. 6,79 mld. | Omzet 2025 * | 7,62 mld. 8,46 mld. 7,77 mld. | Marktkapitalisatie | 38,38 mld. 42,61 mld. 39,14 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 886 mln. 984 mln. 904 mln. | Nettowinst (verlies) 2025 * | 1,1 mld. 1,22 mld. 1,12 mld. | EV/omzet 2024 * | 6,18 x |
Nettoschuld 2024 * | 2,79 mld. 3,1 mld. 2,84 mld. | Nettoschuld 2025 * | 3,4 mld. 3,77 mld. 3,47 mld. | EV/omzet 2025 * | 5,48 x |
K/w-verhouding 2024 * |
43,4
x | K/w-verhouding 2025 * |
34,6
x | Werknemers | - |
Dividendrendement 2024 * |
0,85% | Dividendrendement 2025 * |
0,98% | Vrij verhandelbaar | 95,87% |
Recentste transcriptie over Lonza Group AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25-04-17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01-12-21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16-04-14 |
Director/Board Member | 66 | 16-04-14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05-05-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,46 mld. | |
+1,00% | 42,58 mld. | |
-5,26% | 29,09 mld. | |
+13,68% | 26,61 mld. | |
-22,99% | 18,64 mld. | |
+8,22% | 13,16 mld. | |
+32,41% | 12,55 mld. | |
-1,62% | 11,98 mld. | |
+24,01% | 12,1 mld. |
- Beurs
- Aandelen
- Koers LONN
- Koers